|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication January 29, 2007.
Revised March 21, 2007.
Accepted for publication March 23, 2007.
B-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products Through The Suppression of TAK-1 and RIP Regulated I
B
Kinase Activation
Fisetin (3,7,3',4'-tetrahydroxyflavone) exhibits anti-inflammatory and antiproliferative effects through a mechanism that is poorly understood. Although fisetin has been cocrystalized with cyclin-dependent kinase 6 and inhibits its activity, this inhibition is not sufficient to explain various activities assigned to this flavonol. Because of the critical role of the NF-
B pathway in regulation of inflammation and proliferation of tumor cells, we postulated that fisetin modulates this pathway. To test this hypothesis, we examined the effect of fisetin on NF-
B and NF-
B-regulated gene products in vitro. We found that among nine different flavones tested fisetin was potent in suppressing TNF-induced NF-
B activation. Fisetin also suppressed the NF-
B activation induced by various inflammatory agents and carcinogens; and blocked the phosphorylation and degradation of I
B
by inhibiting I
B
(IKK) activation, which in turn led to suppression of the phosphorylation and nuclear translocation of p65. NF-
B-dependent reporter gene expression was also suppressed by fisetin, as was NF-
B reporter activity induced by TNFR1, TRADD, TRAF2, NIK, and IKK, but not that induced by p65 transfection. Fisetin also inhibited TNF-induced TAK1 and RIP activation, events that lie upstream of IKK activation. The expression of NF-
B-regulated gene products involved in antiapoptosis (cIAP-1/2, Bcl-2, Bcl-xL, XIAP, Survivin, and TRAF1), proliferation (cyclin D1, c-Myc, COX-2), invasion (ICAM-1 and MMP-9) and angiogenesis (VEGF) were also down-regulated by fisetin. This correlated with potentiation of apoptosis induced by TNF, doxorubicin, and cisplatin. Thus overall our results indicate that fisetin mediates antitumor and anti-inflammatory effects through modulation of NF-
B pathways.
Key words:
NFkappaB, Mechanisms of cell killing/apoptosis
This article has been cited by other articles:
![]() |
A.-L. Salmela, J. Pouwels, A. Varis, A. M. Kukkonen, P. Toivonen, P. K. Halonen, M. Perala, O. Kallioniemi, G. J. Gorbsky, and M. J. Kallio Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint Carcinogenesis, June 1, 2009; 30(6): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Lim and J. H. Y. Park Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1060 - G1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sung, A. Murakami, B. O. Oyajobi, and B. B. Aggarwal Zerumbone Abolishes RANKL-Induced NF-{kappa}B Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer-Induced Bone Loss in Athymic Nude Mice Cancer Res., February 15, 2009; 69(4): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khan, M. Asim, F. Afaq, M. Abu Zaid, and H. Mukhtar A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice Cancer Res., October 15, 2008; 68(20): 8555 - 8563. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sung, M. K. Pandey, K. S. Ahn, T. Yi, M. M. Chaturvedi, M. Liu, and B. B. Aggarwal Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-{kappa}B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-{kappa}B{alpha} kinase, leading to potentiation of apoptosis Blood, May 15, 2008; 111(10): 4880 - 4891. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khan, F. Afaq, D. N. Syed, and H. Mukhtar Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells Carcinogenesis, May 1, 2008; 29(5): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||